Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...

Johnson & Johnson JNJ reported positive results from an early-stage study evaluating its investigational intravesical ...

The prospective, multicenter phase 2 RACE-IT trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a high-risk non-muscle invasive bladder ...

Dr. Aleksander Słusarczyk presented the clinical case of a 75-year-old woman who presented with a two-month history of hematuria. Her medical history was notable for diabetes, prior myocardial ...

A metastatic bladder cancer diagnosis changes everything — not just your treatment plan, but also your daily life. In this series, a woman talks candidly with an oncology nurse about how to navigate ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending durvalumab (Imfinzi, AstraZeneca), given with gemcitabine and cisplatin before surgery and ...

CINCINNATI (WKRC) - Local doctors and survivors are raising awareness about the early warning signs of bladder cancer, a disease often difficult to diagnose. Carol Oetzel, a survivor, shared her ...

For most people with bladder cancer, the first red flag is literally red: blood in the urine. But for people with color blindness, that warning sign may be easy to miss — and missing it could prove ...

One of the more common complications is a ureteral obstruction, which is a blockage of the tubes that drain from the kidneys into the bladder. “The tumor can block the ability of urine to flow from ...